Evolution of the Average Target: Stride, Inc.

Evolution of the Target Price: Stride, Inc.

Changes in Analyst Recommendations: Stride, Inc.

53fd9e019.KF7TNU2Hvt9_-p__xHiFy_a-MgQH3BwyHqod3ho2rCQ.egSSRibgj6YJmK_InTfuo4LhdkJImU8BWpp3r1gCgXZMCZJkIsXZpRy2pw~2b9a4e3222f90e6a0d5b8149906b2a2e
25-10-29 Morgan Stanley Lowers Price Target on Stride to $130 From $159, Keeps Equalweight Rating MT
25-10-29 BMO Capital Downgrades Stride to Market Perform From Outperform, Adjusts PT to $108 From $164 MT
25-10-06 Analyst recommendations: Micron, Nike, Stellantis, Microsoft, Newmont Corp… Zonebourse
25-08-29 Barrington Raises Price Target on Stride to $185 From $170, Keeps Outperform Rating MT
25-08-06 Morgan Stanley Raises Price Target on Stride to $159 From $148, Keeps Equalweight Rating MT
25-08-05 Stride Q4 revenue, adjusted EPS beat estimates RE
25-04-30 Barrington Research Adjusts Stride's Price Target to $170 From $150, Keeps Outperform Rating MT
25-04-30 Morgan Stanley Raises Price Target on Stride to $148 From $141, Keeps Equalweight Rating MT
25-04-21 Stride Positioned for 'Beat, Raise' in Fiscal Q3 Amid Strong Enrollments, Morgan Stanley Says MT
25-04-21 Morgan Stanley Raises Price Target on Stride to $141 From $117, Keeps Equalweight Rating MT
25-01-29 Barrington Adjusts Price Target on Stride to $140 From $130, Maintains Outperform Rating MT
24-10-23 Morgan Stanley Raises Price Target on Stride to $94 From $74, Keeps Equalweight Rating MT
24-08-20 Stride Shares Fall After Citigroup Downgrade MT
24-08-20 Citigroup Downgrades Stride to Neutral From Buy, Adjusts Price Target to $90 From $77 MT
24-08-08 Barrington Research Adjusts Stride's PT to $90 From $85, Keeps Outperform Rating MT
24-08-08 Canaccord Genuity Initiates Coverage on Stride With Buy Rating, $94 Price Target MT
24-07-31 Barrington Research Adjusts Stride's Price Target to $85 From $75, Keeps Outperform Rating MT
24-04-24 Morgan Stanley Raises Price Target on Stride to $70 From $65, Cites 'Solid Quarter,' Keeps Equalweight Rating MT
24-01-25 BMO Capital Adjusts Price Target on Stride to $72 From $71, Keeps Outperform Rating MT
24-01-25 Barrington Ups Price Target on Stride to $75 From $70 as Fiscal Q2 Results Surpass Estimates, Maintains Outperform Rating MT
24-01-24 Barrington Research Adjusts Stride's Price Target to $75 From $70, Maintains Outperform Rating MT
23-11-16 BMO Capital Adjusts Stride's Price Target to $67 From $57, Maintains Outperform Rating MT
23-11-16 Morgan Stanley Adjusts Price Target on Stride to $60 From $57, Maintains Equal-Weight Rating MT
23-10-26 BMO Capital Raises Price Target on Stride to $57 From $50, Maintains Outperform Rating MT
23-10-25 Barrington Raises Price Target on Stride to $60 From $50, After Q1/24 Earnings Top Estimates, Maintains Outperform Rating MT

Consensus Analysts' recommendations evolution (4 months) Financial estimates divergence Analysts' Target price divergence Objective/dr gap
+30.64%
+43.39%
+51.35%
+10.62%
+34.88%
+6.34%
+46.49%
- - +44.93%
+37.95%
+17.22%
Average +32.38%
Weighted average by Cap. +33.55%
See all sector consensus

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
3
Last Close Price
90.08USD
Average target price
113.50USD
Spread / Average Target
+26.00%
High Price Target
125.00USD
Spread / Highest target
+38.77%
Low Price Target
102.00USD
Spread / Lowest Target
+13.23%

Analyst Consensus Detail

Consensus revision (last 18 months)

Analysts covering the company

BMO Capital
Morgan Stanley
Barrington Research
Citigroup
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
A
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
3
Last Close Price
90.08USD
Average target price
113.50USD
Spread / Average Target
+26.00%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. LRN Stock
  4. Consensus Stride, Inc.